Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
EfFZjnWA9DGPbD7U
Listen
